HCA Healthcare (NYSE:HCA) hits a new 1-year high of $403.42

VaselineSeptember 19, 2024

0 4 minutes read

Shares of HCA Healthcare, Inc. (NYSE:HCA – Get Your Free Report ) hit a new 52-week high during trading on Monday . The company traded as high as $403.42 and last traded at $402.89, with a volume of 425499 shares traded. Shares previously closed at $394.68.

Changes in Analyst Ratings

A number of analysts have weighed in on the company. Baird RW upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Truist Financial upped their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Monday, August 19th. Leerink Partners upped their price target on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Finally, Morgan Stanley assumed coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price on the stock. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have assigned a strong buy rating to the company’s stock. HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $359.89, according to data from MarketBeat.

See the latest stock analysis on HCA

HCA Healthcare stock rose 0.6%

Want more great investment ideas?

The firm has a market cap of $104.74 billion, a price-to-earnings ratio of 19.93, a PEG ratio of 1.46 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06, and a debt-to-equity ratio of 27.11. The firm has a fifty day moving average price of $367.24 and a 200 day moving average price of $339.56.

HCA Healthcare (NYSE:HCA – Get Your Free Report ) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. In the same quarter last year, the business posted EPS of $4.29. The company’s quarterly revenue was up 10.3% year over year. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare announces dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be given a $0.66 dividend. This represents an annualized dividend of $2.64 and a dividend yield of 0.66%. The ex-dividend date is Monday, September 16. HCA Healthcare’s payout ratio is currently 13.16%.

Insider trading at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The sale was disclosed in a filing with the SEC, which is accessible via this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now owns 17,755 shares in the company, valued at $6,303,912.75. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 17,202 shares of company stock worth $6,407,273. Insiders hold 1.60% of the company’s shares.

Institutional investors weigh in on HCA Healthcare

A number of hedge funds have recently made changes to their positions in HCA. Bangor Savings Bank raised its stake in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the last quarter. MFA Wealth Advisors LLC bought a new position in HCA Healthcare in the second quarter valued at approximately $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC boosted its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares during the last quarter. Finally, LifeSteps Financial Inc. bought a new stake in HCA Healthcare in the 1st quarter worth about $33,000. Institutional investors own 62.73% of the company’s shares.

HCA Healthcare Company Profile

(Get a free report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that provide medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic and emergency services; and outpatient services such as ambulatory surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.